Pilot testing a novel, theoretically derived psychological intervention for cancer-related anxiety

The University of Sydney0 个研究点目标入组 12 人开始时间: 2018年3月21日最近更新: 2021年7月12日

适应症

试验速览

暂无简介。

•Patients with a diagnosis of metastatic cancer or patients who have experienced a recurrence or progression of their cancer or a second cancer diagnosis
•Aged 18 or over
•Fluent in English
•Clinically significant anxiety as measured by a score of 8 or more on the Hospital Anxiety and Depression Scale– Anxiety subscale (HADS-A, Zigmond & Snaith, 1983) OR a score of 19 or more on the Impact of Events Scale - Revised (Weiss & Marmar, 1997) OR a score of 34 or more on the Fear of Progression questionnaire, Short version (Mehnert, Herschbach, Berg, Henrich, & Koch, 2006).
•Willingness to give written informed consent and willingness to participate to and comply with the study.

•Mental health condition predating cancer diagnosis requiring ongoing treatment, such as major depression, bipolar, psychosis, borderline personality disorder or substance dependence
•Current suicidal risk.
•Receiving concurrent psychological treatment
•Taking psychotropic medication unless
•1) the dose has been stable for at least 8 weeks
•2) the medication was prescribed as a pre-medication before chemotherapy treatment or a medical procedure or
•3) the medication was prescribed specifically to treat nausea.
•Cognitive impairment as measured by a score of <27 on the Telephone Interview for Cognitive Status - modified (Brandt, Spencer, & Folstein, 1988; Welsh, Breitner, & Magruder-Habib, 1993)

发起方